Cargando…
NK cells beat T cells at early breast cancer control
Cancer immunosurveillance generally relies on adaptive immune programs executed by CD8(+) T cells. Our findings demonstrate that CD8(+) T cells fail to control early oncogenesis in a mouse model of luminal B breast cancer and suggest that natural killer (NK) cells may instead play a predominant role...
Autores principales: | Buque, Aitziber, Bloy, Norma, Petroni, Giulia, Kroemer, Guido, Galluzzi, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458610/ https://www.ncbi.nlm.nih.gov/pubmed/32923169 http://dx.doi.org/10.1080/2162402X.2020.1806010 |
Ejemplares similares
-
Immunofluorescence microscopy-based assessment of cytosolic DNA accumulation in mammalian cells
por: Sato, Ai, et al.
Publicado: (2021) -
Cellular senescence in the response of HR(+) breast cancer to radiotherapy and CDK4/6 inhibitors
por: Klapp, Vanessa, et al.
Publicado: (2023) -
LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells
por: Yamazaki, Takahiro, et al.
Publicado: (2021) -
Nicotinamide drives T cell activation in the mammary tumor microenvironment
por: Hu, Yang, et al.
Publicado: (2022) -
Trial Watch: Peptide-based anticancer vaccines
por: Pol, Jonathan, et al.
Publicado: (2015)